Quest Diagnostics (DGX) Revenue — Quarter Ended Dec 31, 2023
Revenue for the quarter decreased compared to both the immediately preceding quarter and the same quarter one year earlier. The decline continues a pattern of year-over-year contraction observed in each quarter of the reporting period.
Key takeaway
Quarter ended Dec 31, 2023 · FY2023 Q4
Revenue for the quarter decreased compared to both the immediately preceding quarter and the same quarter one year earlier. The decline continues a pattern of year-over-year contraction observed in each quarter of the reporting period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.3B
Revenue reported for this quarter.
Quarter-over-quarter
-0.3%
Change from the immediately preceding quarter.
Year-over-year
-1.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$9.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2023 | $2.3B | -10.7% |
| Jun 30, 2023 | $2.3B | -4.7% |
| Sep 30, 2023 | $2.3B | -7.7% |
| Dec 31, 2023 | $2.3B | -1.9% |
Revenue performance
Revenue contracted from the prior quarter, with the sequential decline modest. The year-over-year decrease was more pronounced.
Quarterly comparison
The sequential decline was slight, while the year-over-year decrease was larger. Both comparisons show lower revenue, consistent with the full-year trend of negative comparable-period changes.
What to watch
The persistent year-over-year revenue declines across all quarters of the period may signal ongoing headwinds.